Familial hypercholesterolaemia: open trials in Greece

• 2024-514595-41-00

  Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharma AG

  University General Hospital of Ioannina, Ioannina · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2026-10-26

• NCT06597006

  Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Ioannina · Thessaloniki

  Registry updated 2026-07-24

• NCT06597019

  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Athens · Ioannina

  Registry updated 2026-05-15

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error